Cervical carcinoma progression is aggravated by lncRNA ZNF281 by binding KLF15

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cervical carcinoma progression is influenced by complex molecular mechanisms.
• Long non-coding RNAs (lncRNAs) play critical roles in cancer development.
• Understanding the specific roles of lncRNAs like ZNF281 is crucial for identifying therapeutic targets.

Purpose of the Study:

• To investigate the biological functions of lncRNA ZNF281 and KLF15 in cervical carcinoma.
• To determine the regulatory relationship between ZNF281 and KLF15 in cervical cancer progression.
• To evaluate ZNF281 as a potential biomarker for cervical carcinoma.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) to assess ZNF281 expression in tissues and cell lines.
• In vitro assays (transwell, wound healing) to evaluate cell migration after ZNF281 knockdown.
• In vivo xenograft models in nude mice to assess tumorgenicity.
• Bioinformatics and Dual-Luciferase reporter assays to identify and validate downstream targets.

Main Results:

• ZNF281 expression was significantly upregulated in cervical carcinoma tissues and cell lines.
• ZNF281 upregulation correlated with advanced TNM staging, lymphatic, and distant metastasis.
• Knockdown of ZNF281 inhibited cervical carcinoma cell migration and reduced tumor growth in vivo.
• KLF15 was identified as a direct downstream target of ZNF281, with a negative correlation in tumor tissues.

Conclusions:

• lncRNA ZNF281 is oncogenic in cervical carcinoma, promoting migration and metastasis.
• ZNF281 exerts its effects by targeting and regulating KLF15.
• ZNF281 represents a promising diagnostic and prognostic biomarker for cervical carcinoma.